SEC Filing Summary: Carlyle Group Inc. (Form 13F)
Business Context and Reporting Period
This filing is a Form 13F Information Table submitted by Carlyle Group Inc. for the reporting period ending March 31, 2025. The document discloses the investment manager's holdings in equity securities, detailing the number of shares, value, and voting authority for each position.
Key Financial Metrics and Holdings
The filing does not report Carlyle Group's own revenue, profit, cash flow, or debt metrics. Instead, it lists specific equity positions held by the manager. Key holdings include:
- Standardaero Inc: 134,352,830 shares valued at approximately $3.58 billion.
- Phathom Pharmaceuticals Inc: 3,496,808 shares valued at approximately $21.92 million.
- Weride Inc: 3,423,023 shares valued at approximately $46.45 million.
- Smart Sh Global Ltd: 4,362,929 shares valued at approximately $4.89 million.
- Adicet Bio Inc: 2,948,718 shares valued at approximately $2.28 million.
The filing lists 23 distinct issuers with a mix of sole, shared, and none voting authority. The "Value" column represents the aggregate market value of the holdings as of the reporting date.
Material Changes
The filing text provided is a static snapshot of holdings as of March 31, 2025. It does not contain comparative data against the prior quarter (December 31, 2024) or year-over-year figures. Therefore, material changes in position size or new entries cannot be determined from this document alone.
Guidance, Outlook, and Risks
This Form 13F filing does not contain management commentary, financial guidance, outlook statements, or risk factors. It is a regulatory disclosure of portfolio composition. The filing includes a standard disclaimer that the SEC has not reviewed the information for accuracy or completeness.
Investor Verification Checklist
- Verify the total aggregate value of the reported portfolio against Carlyle Group's broader quarterly earnings reports.
- Compare these holdings against the previous quarter's Form 13F to identify new entries or exits.
- Confirm the accuracy of the "Value" column against market prices on March 31, 2025, given the large position in Standardaero Inc.
- Review the "Voting Authority" column to understand the level of control or influence Carlyle holds in these specific companies.